Journal of Bone Oncology
The Journal of Bone Oncology is a peer-reviewed international journal aimed at presenting basic, translational and clinical high-quality research related to bone and cancer. As the first journal dedicated to cancer induced bone diseases, JBO welcomes original research articles, review articles, editorials, case reports and opinion pieces. The areas covered by the journal include:
- Bone metastases (pathophysiology, epidemiology, diagnostics, clinical features, prevention, treatment)
- Preclinical models of metastasis
- Bone microenvironment in cancer (stem cell, bone cell and cancer interactions)
- Bone targeted therapy (pharmacology, therapeutic targets, drug development, clinical trials, side-effects, outcome research, health economics)
- Cancer treatment induced bone loss (epidemiology, pathophysiology, prevention and management)
- Bone imaging (clinical and animal, skeletal interventional radiology)
- Bone biomarkers (clinical and translational applications)
- Radiotherapy and radio-isotopes
- Skeletal complications
- Bone pain (mechanisms and management)
- Orthopaedic cancer surgery
- Primary bone tumours
- Clinical guidelines
- Multidisciplinary care
Keywords: bisphosphonate, bone, breast cancer, cancer, CTIBL, denosumab, metastasis, myeloma, osteoblast, osteoclast, osteooncology, osteo-oncology, prostate cancer, skeleton, tumour
Editors-in-Chief: Robert Coleman , Peyman Hadji
Imprint: Elsevier
ISSN: 2212-1374
Open access
News
Most cited
Top 10 Cited (articles published in the last five years)
Extracted from Scopus (on Fri Jun 28)Heymann, D. Anti-RANKL therapy for bonetumours: Basic, pre-clinical and clinical evidences Journal of Bone Oncology, Volume 1, Issue 1, 2012-06-01, Pages 2-11 - View all items
Recent articles
Fri Jun 281 Brian Hutton | Patricia Morretto | Urban Emmenegger | Sasha Mazarello | Iryna Kuchuk | Christina L. Addison | Freya Crawley | C Canil | Shawn Malone | Scott Berry | Dean Fergusson | Mark Clemons Bone-Targeted Agent Use For Bone Metastases From Breast Cancer and Prostate Cancer: A Patient Survey Journal of Bone Oncology, Available online 21 June 2013 2 Tilman D. Rachner | Andy Göbel | Maria Junker | Josefa Hötzel | Peggy Benad-Mehner | Peyman Hadji | Lorenz C. Hofbauer Regulation of VEGF by mevalonate pathway inhibition in breast cancer Journal of Bone Oncology, Available online 7 June 2013 3 Gaëlle Picarda | Etienne Matous | Jérôme Amiaud | Céline Charrier | François Lamoureux | Marie-Françoise Heymann | Franck Tirode | Bruno Pitard | Valérie Trichet | Dominique Heymann | Françoise Redini Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL Journal of Bone Oncology, Available online 20 May 2013 4 Brian Hutton | Christina L. Addison | Kaitryn Campbell | Dean Fergusson | Sasha Mazarello | Mark Clemons A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer Journal of Bone Oncology, Available online 15 May 2013 5 Rebecca Silbermann | G. David Roodman Myeloma bone disease: Pathophysiology and management Journal of Bone Oncology, Volume 2, Issue 2, June 2013, Pages 59-69 6 Gillian Bedard | Edward Chow The failures and challenges of bone metastases research in radiation oncology Journal of Bone Oncology, Volume 2, Issue 2, June 2013, Pages 84-88 7 Copyright Page / Barcode Journal of Bone Oncology, Volume 2, Issue 2, June 2013, Pages III- 8 Brian Hutton | Christina Addison | Sasha Mazzarello | Anil A. Joy | Nathaniel Bouganim | Dean Fergusson | Mark Clemons De-escalated administration of bone-targeted agents in patients with breast and prostate cancer𢀔A survey of Canadian oncologists Journal of Bone Oncology, Volume 2, Issue 2, June 2013, Pages 77-83 9 Robert E. Coleman | Allan Lipton | Luis Costa | Richard J. Cook | Ker-Ai Lee | Fred Saad | Janet E. Brown | Evangelos Terpos | Pierre P. Major | Norio Kohno | Matthew Smith | Jean-Jacques Body Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features𢀔An exploratory analysis of placebo-controlled trials Journal of Bone Oncology, Volume 2, Issue 2, June 2013, Pages 70-76 10 Debdutta Chatterjee | Kiran Kumar Mukhopadhyay | Sanjay Kumar | Sudipta Chakraborty The rare aggressive osteoblastoma in a two year old child in an unusual localization Journal of Bone Oncology, Volume 2, Issue 2, June 2013, Pages 89-91 - View all items

